555 related articles for article (PubMed ID: 29340620)
21. Antiviral activity of a polysaccharide from Radix Isatidis (Isatis indigotica Fortune) against hepatitis B virus (HBV) in vitro via activation of JAK/STAT signal pathway.
Wang T; Wang X; Zhuo Y; Si C; Yang L; Meng L; Zhu B
J Ethnopharmacol; 2020 Jul; 257():112782. PubMed ID: 32217096
[TBL] [Abstract][Full Text] [Related]
22. Ubiquitin-modified hepatitis B virus core antigen effectively facilitates antigen presentation and enhances cytotoxic T lymphocyte activity via the cytoplasmic transduction peptide in vitro.
Song L; Zhuo M; Tang Y; Chen X; Yu Y; Tang Z; Zang G
Mol Med Rep; 2015 Jul; 12(1):289-96. PubMed ID: 25684256
[TBL] [Abstract][Full Text] [Related]
23. Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1.
Saudemont A; Hamrouni A; Marchetti P; Liu J; Jouy N; Hetuin D; Colucci F; Quesnel B
Cancer Res; 2007 May; 67(9):4491-8. PubMed ID: 17483365
[TBL] [Abstract][Full Text] [Related]
24. Blockade of Janus kinase-2 signaling ameliorates mouse liver damage due to ischemia and reperfusion.
Freitas MC; Uchida Y; Zhao D; Ke B; Busuttil RW; Kupiec-Weglinski JW
Liver Transpl; 2010 May; 16(5):600-10. PubMed ID: 20440769
[TBL] [Abstract][Full Text] [Related]
25. [HBcAg-specific CTL response induced by PTD-HBcAg fusion protein to inhibit HBV replication in vitro].
Chen XH; Pan QC; Yu YS; Tang ZH; Zang GQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):289-92. PubMed ID: 19351491
[TBL] [Abstract][Full Text] [Related]
26. Immune responses of human T lymphocytes to novel hepatitis B virus-derived peptides.
Yamamiya D; Mizukoshi E; Kaji K; Terashima T; Kitahara M; Yamashita T; Arai K; Fushimi K; Honda M; Kaneko S
PLoS One; 2018; 13(6):e0198264. PubMed ID: 29856876
[TBL] [Abstract][Full Text] [Related]
27. Induction of CTL responses and identification of a novel epitope of hepatitis B virus surface antigens in C57BL/6 mice immunized with recombinant vaccinia viruses.
Roh S; Lee YK; Ahn BY; Kim K; Moon A
Virus Res; 2001 Jan; 73(1):17-26. PubMed ID: 11163641
[TBL] [Abstract][Full Text] [Related]
28. The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice.
Chen X; Lai J; Pan Q; Tang Z; Yu Y; Zang G
Vaccine; 2010 May; 28(23):3913-9. PubMed ID: 20394723
[TBL] [Abstract][Full Text] [Related]
29. p43 induces IP-10 expression through the JAK-STAT signaling pathway in HMEC-1 cells.
Wang W; Tan J; Xing Y; Kan N; Ling J; Dong G; Liu G; Chen H
Int J Mol Med; 2016 Oct; 38(4):1217-24. PubMed ID: 27574027
[TBL] [Abstract][Full Text] [Related]
30. Liraglutide Exerts Potential Anti-inflammatory Effect in Type 1 Diabetes by Inhibiting IFN-γ Production
Zhao Y; Xie Y; Li W
Endocr Metab Immune Disord Drug Targets; 2019; 19(5):656-664. PubMed ID: 30827273
[TBL] [Abstract][Full Text] [Related]
31. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
Shimizu Y; Guidotti LG; Fowler P; Chisari FV
J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
[TBL] [Abstract][Full Text] [Related]
32. Chicken IL-26 regulates immune responses through the JAK/STAT and NF-κB signaling pathways.
Truong AD; Hong Y; Hoang CT; Lee J; Hong YH
Dev Comp Immunol; 2017 Aug; 73():10-20. PubMed ID: 28259699
[TBL] [Abstract][Full Text] [Related]
33. Baricitinib Ameliorates Experimental Autoimmune Encephalomyelitis by Modulating the Janus Kinase/Signal Transducer and Activator of Transcription Signaling Pathway.
Dang C; Lu Y; Chen X; Li Q
Front Immunol; 2021; 12():650708. PubMed ID: 33927721
[TBL] [Abstract][Full Text] [Related]
34. An Engineered DC-Targeting Lentivector Induces Robust T Cell Responses and Inhibits HBV Replication in HBV Transgenic Mice via Upregulating T Cell Autophagy.
Ma S; Chen X; Tan Q; Dai S; Li D; Wu S; Yu Y; Zang G; Tang Z
Cell Physiol Biochem; 2018; 48(3):1041-1059. PubMed ID: 30041239
[TBL] [Abstract][Full Text] [Related]
35. The antagonist of the JAK-1/STAT-1 signaling pathway improves the severity of cerulein-stimulated pancreatic injury via inhibition of NF-κB activity.
Chen P; Huang L; Zhang Y; Qiao M; Yao W; Yuan Y
Int J Mol Med; 2011 May; 27(5):731-8. PubMed ID: 21369693
[TBL] [Abstract][Full Text] [Related]
36. TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK-STAT signaling pathway.
Zhu X; Xie C; Li YM; Huang ZL; Zhao QY; Hu ZX; Wang PP; Gu YR; Gao ZL; Peng L
Cell Death Dis; 2016 Jun; 7(6):e2239. PubMed ID: 27253403
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.
van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM
J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316
[TBL] [Abstract][Full Text] [Related]
38. IFN-CSP inhibiting hepatitis B virus in HepG2.2.15 cells involves JAK-STAT signal pathway.
Lu X; Wang J; Jin X; Huang Y; Zeng W; Zhu J
Biomed Res Int; 2015; 2015():959684. PubMed ID: 25861653
[TBL] [Abstract][Full Text] [Related]
39. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
Coskun M; Salem M; Pedersen J; Nielsen OH
Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
[TBL] [Abstract][Full Text] [Related]
40. Correlation between low tapasin expression and impaired CD8+ T‑cell function in patients with chronic hepatitis B.
Tang Y; Wang J; Zhang Y; Zhuo M; Song L; Tang Z; Zang G; Chen X; Yu Y
Mol Med Rep; 2016 Oct; 14(4):3315-22. PubMed ID: 27510296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
